BFI Infinity Ltd. Purchases New Stake in McKesson Corporation $MCK

BFI Infinity Ltd. acquired a new position in shares of McKesson Corporation (NYSE:MCK) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 3,725 shares of the company’s stock, valued at approximately $3,056,000. McKesson comprises approximately 1.9% of BFI Infinity Ltd.’s holdings, making the stock its 12th largest holding.

Other hedge funds have also added to or reduced their stakes in the company. GGM Financials LLC purchased a new stake in shares of McKesson during the 3rd quarter worth approximately $25,000. State of Wyoming bought a new stake in shares of McKesson in the 2nd quarter worth approximately $29,000. Hopwood Financial Services Inc. purchased a new position in McKesson in the third quarter valued at approximately $31,000. Vermillion & White Wealth Management Group LLC purchased a new position in McKesson in the third quarter valued at approximately $33,000. Finally, Board of the Pension Protection Fund bought a new position in McKesson during the fourth quarter valued at $33,000. Institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Michele Lau sold 2,725 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total value of $2,697,750.00. Following the completion of the transaction, the executive vice president owned 3,247 shares of the company’s stock, valued at $3,214,530. The trade was a 45.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction on Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,868 shares of company stock valued at $3,743,820 over the last quarter. Company insiders own 0.08% of the company’s stock.

McKesson Stock Down 0.4%

Shares of NYSE MCK opened at $860.41 on Friday. The firm has a market capitalization of $105.39 billion, a P/E ratio of 24.75, a P/E/G ratio of 1.38 and a beta of 0.38. The stock’s 50-day simple moving average is $907.62 and its two-hundred day simple moving average is $839.75. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same quarter last year, the company posted $8.03 EPS. The company’s revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, research analysts anticipate that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s payout ratio is presently 9.43%.

Analyst Ratings Changes

A number of research firms have issued reports on MCK. JPMorgan Chase & Co. raised their target price on McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Evercore reaffirmed an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Mizuho increased their price target on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Weiss Ratings lowered McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Finally, Wells Fargo & Company boosted their price objective on McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. Thirteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and a consensus target price of $960.93.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.